Skip to main content
Công ty Cổ phần Dược phẩm Cửu Long logo

Công ty Cổ phần Dược phẩm Cửu Long — Investor Relations & Filings

Ticker · DCL ISIN · VN000000DCL1 HSX Manufacturing
Open in API
Filings indexed 224 across all filing types
Latest filing 2026-05-07 Governance Information
Country VN Viet Nam
Listing HSX DCL

About Công ty Cổ phần Dược phẩm Cửu Long

http://dcl.com.vn

Cuu Long Pharmaceutical Joint Stock Company (DCL) is a diversified healthcare provider with nearly 50 years of operational history. The company's core activities include the production of pharmaceuticals, medical equipment, and empty hard capsules. DCL is a market leader in empty hard capsules, holding approximately 80% market share. Its pharmaceutical portfolio comprises a range of drugs, chemicals, and medicines. The company serves a broad network of hospitals and medical facilities through an extensive distribution system. DCL is recognized for its commitment to delivering innovative and accessible healthcare products.

Recent filings

Filing Released Lang Actions
DCL: Điều lệ công ty
Governance Information Classification · 90% confidence The document is an Extraordinary Information Disclosure to the HCM Stock Exchange that provides the full amended Company Charter (“Điều lệ”) following shareholder approval. It contains the complete text of the internal governance rules, board structure, shareholder meeting procedures, etc., rather than merely announcing or linking to a report. This is a governance document, fitting “Governance Information” (CGR).
2026-05-07 Vietnamese
DCL: Giấy xác nhận về việc thay đổi nội dung đăng ký doanh nghiệp
Regulatory Filings Classification · 87% confidence The document is an extraordinary information disclosure filed with the State Securities Commission and Ho Chi Minh Stock Exchange, announcing a change in the company’s business registration details and attaching the official certificate. It is neither a financial report, earnings release, nor management presentation but a general regulatory announcement required by Vietnamese securities authorities. Therefore, it falls under the fallback category for miscellaneous regulatory filings.
2026-05-06 Vietnamese
DCL: Thông báo thay đổi nhân sự
Board/Management Information Classification · 95% confidence The document is a formal company announcement of a change in senior management (appointment of a Deputy General Director) issued under board resolutions. It is clearly a Board/Management Information notice regarding personnel changes, matching the MANG category.
2026-05-05 Vietnamese
DCL: Nghị quyết, Biên bản họp ĐHĐCĐ thường niên 2026 và Biên bản kiểm phiếu
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an issuer disclosure to the Vietnamese securities regulator and stock exchange announcing and attaching the minutes, vote counting minutes, and resolutions of the 2026 Annual General Meeting of shareholders, including detailed voting results. This corresponds to an official declaration of AGM voting outcomes. Accordingly, it should be classified under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-28 Vietnamese
DCL: Giải trình biến động LNST quý 1/2026 so với cùng kỳ năm trước
Regulatory Filings Classification · 85% confidence The document is a required regulatory disclosure under Vietnams Circular 96/2020/TT-BTC, providing an explanation of the variance in post-tax quarterly profit for Q1 2026 vs Q1 2025 on separate and consolidated financial statements. It is addressed to the State Securities Commission and Ho Chi Minh Stock Exchange, but it is not the full interim/quarterly report (it contains only profit variances and explanations, not comprehensive financial statements). Therefore it is a regulatory filing announcement rather than an Interim Report. It falls into the "Regulatory Filings" (RNS) category.
2026-04-28 Vietnamese
DCL: Cập nhật tài liệu ĐHĐCĐ thường niên năm 2026
AGM Information Classification · 92% confidence The document is an extraordinary 24-hour disclosure filing by Cuu Long Pharmaceutical JSC providing updated materials for the 2026 Annual General Meeting of Shareholders, including the AGM agenda, draft board and management reports, resolutions, and supporting documents. These are the actual meeting materials, not just an announcement of a report. Therefore, it fits the AGM Information category.
2026-04-22 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.